Skip to content
Home/Companies/Healthcare/Abacus Pharmaceuticals
Abacus Pharmaceuticals

Abacus Pharmaceuticals

Healthcare·US·Active
Entry
–
Hold
–
Status
Active

Who owns Abacus Pharmaceuticals?

Abacus Pharmaceuticals is currently owned by The Carlyle Group through Carlyle Sub-Saharan Africa Fund (2018 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQUSA
SectorHealthcare
Websiteabacuspharma.com

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
HospitalityUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to
Amrod
Amrod
Exited 2023
ConsumerUS
to
CMC Networks
CMC Networks
Active
TelecomSouth Africa
Every Man Jack
Every Man Jack
Active
ConsumerUS

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS
Track Abacus Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Abacus Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Abacus Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue